Original InvestigationRandomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial

Joshua M. Hare,Darcy L. DiFede,Angela C. Rieger,Victoria Florea,Ana Marie Landin,Jill El-Khorazaty,Aisha Khan,Muzammil Mushtaq,Maureen H. Lowery,John J. Byrnes,Robert C. Hendel,Mauricio G. Cohen,Carlos Alfonso,Krystalenia Valasaki,Marietsy V. Pujol,Samuel Golpanian,Eduard Ghersin,Joel E. Fishman,Alan W. Heldman

Original InvestigationRandomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial

2017

Joshua M. Hare
Darcy L. DiFede
Angela C. Rieger
Victoria Florea
Ana Marie Landin
Jill El-Khorazaty
Aisha Khan
Muzammil Mushtaq
Maureen H. Lowery
John J. Byrnes
Robert C. Hendel
Mauricio G. Cohen
Carlos Alfonso
Krystalenia Valasaki
Marietsy V. Pujol
Samuel Golpanian
Eduard Ghersin
Joel E. Fishman
Alan W. Heldman

Background Although human mesenchymal stem cells (hMSCs) have been tested in ischemic cardiomyopathy, few studies exist in chronic nonischemic dilated cardiomyopathy (NIDCM).

Keywords:

Stem-cell therapy
Dilated cardiomyopathy
Mace
Heart failure
Mesenchymal stem cell
Diabetes mellitus
Cardiology
Internal medicine
Medicine
Ischemic cardiomyopathy
dilative cardiomyopathy
idiopathic dilated cardiomyopathy

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations